<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2025-11-1-0-4</article-id><article-id pub-id-type="publisher-id">3683</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Genetic variants of sex hormone-binding globulin and hormonal profile in patients with genital endometriosis&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Genetic variants of sex hormone-binding globulin and hormonal profile in patients with genital endometriosis&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ponomareva</surname><given-names>Tatyana A.</given-names></name><name xml:lang="en"><surname>Ponomareva</surname><given-names>Tatyana A.</given-names></name></name-alternatives><email>rybaarbusova@icloud.com</email></contrib></contrib-group><pub-date pub-type="epub"><year>2025</year></pub-date><volume>11</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2025/1/Биомед-76-91.pdf" /><abstract xml:lang="ru"><p>Background: Endometriosis is a chronic inflammatory, dyshormonal disease. Genetic factors play an important role in its development. Sex hormone imbalance is important for the occurrence, growth and spread of endometrioid heterotopias. The aim of the study: To investigate the association of gene polymorphism associated with the level of sex hormone-binding globulin (SHBG) with the hormonal profile of patients with genital endometriosis. Materials and methods: A study was conducted on a sample of 103 women with genital endometriosis. Each patient underwent an analysis of sex hormone levels (dehydroepiandrosterone (DHEA), estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone, prolactin and testosterone). Genotyping of nine single-nucleotide polymorphisms (SNPs) significant for SHBG levels according to genome-wide association study (GWAS) data was performed: rs12150660 of the SHBG gene, rs10454142 of the PPP1R21 gene, rs780093 of the GCKR gene, rs17496332 of the PRMT6 gene, rs3779195 of the BAIAP2L1 gene, rs440837 of the ZBTB10 gene, rs7910927 of the JMJD1C gene, rs4149056 of the SLCO1B1 gene, rs8023580 of the NR2F2 gene. Using the gPLINK program, the association of the above loci with the level of sex hormones in women with genital endometriosis was assessed using the linear regression method. Results: Genetic variants associated with SHBG levels that determine the hormonal profile of patients with endometriosis have been identified. The polymorphic loci associated with the content of dehydroepiandrosterone and testosterone are rs440837 ZBTB10 (allele G, &amp;beta;=-0.266 - -0.334, pperm&amp;le;0.050 and &amp;beta;=-0.322 - -0.215, pperm &amp;le;0.050, respectively), estradiol &amp;ndash; rs3779195 BAIAP2L1 (allele A, &amp;beta;=-0.282 - -0.318, pperm&amp;le;0.050) and rs440837 ZBTB10 (allele G, &amp;beta;=-0.264, pperm=0.048), progesterone &amp;ndash; rs780093 GCKR (allele T, &amp;beta;=-0.380 - -0.269, pperm&amp;le;0.050), rs10454142 PPP1R21 (allele C, &amp;beta;=0.568, pperm=0.049), rs8023580 NR2F2 (allele C, &amp;beta;=-0.289, pperm=0.050) and rs12150660 SHBG (allele T, &amp;beta;=-1.071, pperm=0.028). Conclusion: Associations of gene polymorphism associated with SHBG levels according to GWAS data with the level of sex hormones in patients with genital endometriosis have been established</p></abstract><trans-abstract xml:lang="en"><p>Background: Endometriosis is a chronic inflammatory, dyshormonal disease. Genetic factors play an important role in its development. Sex hormone imbalance is important for the occurrence, growth and spread of endometrioid heterotopias. The aim of the study: To investigate the association of gene polymorphism associated with the level of sex hormone-binding globulin (SHBG) with the hormonal profile of patients with genital endometriosis. Materials and methods: A study was conducted on a sample of 103 women with genital endometriosis. Each patient underwent an analysis of sex hormone levels (dehydroepiandrosterone (DHEA), estradiol, follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone, prolactin and testosterone). Genotyping of nine single-nucleotide polymorphisms (SNPs) significant for SHBG levels according to genome-wide association study (GWAS) data was performed: rs12150660 of the SHBG gene, rs10454142 of the PPP1R21 gene, rs780093 of the GCKR gene, rs17496332 of the PRMT6 gene, rs3779195 of the BAIAP2L1 gene, rs440837 of the ZBTB10 gene, rs7910927 of the JMJD1C gene, rs4149056 of the SLCO1B1 gene, rs8023580 of the NR2F2 gene. Using the gPLINK program, the association of the above loci with the level of sex hormones in women with genital endometriosis was assessed using the linear regression method. Results: Genetic variants associated with SHBG levels that determine the hormonal profile of patients with endometriosis have been identified. The polymorphic loci associated with the content of dehydroepiandrosterone and testosterone are rs440837 ZBTB10 (allele G, &amp;beta;=-0.266 - -0.334, pperm&amp;le;0.050 and &amp;beta;=-0.322 - -0.215, pperm &amp;le;0.050, respectively), estradiol &amp;ndash; rs3779195 BAIAP2L1 (allele A, &amp;beta;=-0.282 - -0.318, pperm&amp;le;0.050) and rs440837 ZBTB10 (allele G, &amp;beta;=-0.264, pperm=0.048), progesterone &amp;ndash; rs780093 GCKR (allele T, &amp;beta;=-0.380 - -0.269, pperm&amp;le;0.050), rs10454142 PPP1R21 (allele C, &amp;beta;=0.568, pperm=0.049), rs8023580 NR2F2 (allele C, &amp;beta;=-0.289, pperm=0.050) and rs12150660 SHBG (allele T, &amp;beta;=-1.071, pperm=0.028). Conclusion: Associations of gene polymorphism associated with SHBG levels according to GWAS data with the level of sex hormones in patients with genital endometriosis have been established</p></trans-abstract><kwd-group xml:lang="ru"><kwd>genital endometriosis</kwd><kwd>sex hormones</kwd><kwd>polymorphism</kwd><kwd>associations</kwd></kwd-group><kwd-group xml:lang="en"><kwd>genital endometriosis</kwd><kwd>sex hormones</kwd><kwd>polymorphism</kwd><kwd>associations</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Crump J, Suker A, White L. Endometriosis: A review of recent evidence and guidelines. Australian Journal of General Practice. 2024;53(1-2):11-18. DOI: https://doi.org/10.31128/AJGP/04-23-6805</mixed-citation></ref><ref id="B2"><mixed-citation>Koninckx PR, Fernandes R, Ussia A, et al. Pathogenesis Based Diagnosis and Treatment of Endometriosis. Frontiers in Endocrinology (Lausanne). 2021;12:745548. DOI: https://doi.org/10.3389/fendo.2021.745548</mixed-citation></ref><ref id="B3"><mixed-citation>Wang PH, Yang ST, Chang WH, et al. Endometriosis: Part I. Basic concept. Taiwanese Journal of Obstetrics and Gynecology. 2022;61(6):927-934. DOI: https://doi.org/10.1016/j.tjog.2022.08.002</mixed-citation></ref><ref id="B4"><mixed-citation>Smolarz B, Szyłło K, Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). International Journal of Molecular Sciences. 2021;22(19):10554. DOI: https://doi.org/10.3390/ijms221910554</mixed-citation></ref><ref id="B5"><mixed-citation>Adamyan LV, Andreeva EN. The rarest forms of endometriosis. Russian Journal of Human Reproduction. 2022;28(1):45-53. Russian. DOI: https://doi.org/10.17116/repro20222801145</mixed-citation></ref><ref id="B6"><mixed-citation>Ponomareva TA, Altukhova OB, Ponomarenko IV, et al. Novel concepts in the pathogenesis and risk factors of endometriosis.</mixed-citation></ref><ref id="B7"><mixed-citation>Obstetrics and Gynecology. 2024;(7):12-20 Russian. DOI: https://dx.doi.org/10.18565/aig.2024.110</mixed-citation></ref><ref id="B8"><mixed-citation>Zondervan KT, Becker CM, Missmer SA. Endometriosis. New England&amp;nbsp;Journal&amp;nbsp;of Medicine. 2020;382(13):1244-1256. DOI: https://doi.org/10.1056/NEJMra1810764</mixed-citation></ref><ref id="B9"><mixed-citation>Ponomarenko MS, Reshetnikov EA, Churnosova MM, et al. Comorbidity and syntropy of benign proliferative diseases of the female reproductive system: non-genetic, genetic, and epigenetic factors (review). Research Results in Biomedicine. 2023;9(4):544-556. DOI: https://doi.org/10.18413/2658- 6533-2023-9-4-0-9</mixed-citation></ref><ref id="B10"><mixed-citation>Ponomareva TA, Altukhova OB, Ponomarenko IV, et al. Genetic basis of endometriosis comorbidity. Meditsinskiy sovet = Medical Council. 2024;(17):92-102. Russian. DOI: https://doi.org/10.21518/ms2024-497</mixed-citation></ref><ref id="B11"><mixed-citation>Radzinsky VE, Altuchova OB. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018;4(3):28-37. Russian. DOI: https://doi.org/10.18413/2313-8955-2018-4-3-0-3</mixed-citation></ref><ref id="B12"><mixed-citation>Ponomarenko IV, Polonikov AV, Verzilina IN, et al. Molecular-genetic determinants of the development of endometriosis. Gynecology, Obstetrics and Perinatology. 2019;18(1):82-86. Russian. DOI: https://doi.org/10.20953/1726-1678-2019-1-82-86</mixed-citation></ref><ref id="B13"><mixed-citation>Ponomareva TA, Altukhova OB, Ponomarenko IV, et al. The role of genetic factors in developing endometrioid lesions. Obstetrics, Gynecology and Reproduction. 2023;17(4):443-454. Russian. DOI: https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.434</mixed-citation></ref><ref id="B14"><mixed-citation>Ponomarenko IV, Polonikov AV, Churnosov MI. Molecular mechanisms of and risk factors for endometriosis. Obstetrics and Gynecology. 2019;3:26-31. Russian. DOI: https://doi.org/10.18565/aig.2019.3.26-31</mixed-citation></ref><ref id="B15"><mixed-citation>Narinx N, David K, Walravens J, et al. Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.&amp;nbsp;Cellular and Molecular Life Sciences. 2022;79(11):543. DOI: https://doi.org/10.1007/s00018-022-04562-1</mixed-citation></ref><ref id="B16"><mixed-citation>Simons PIHG, Valkenburg O, Stehouwer CDA, et al. Sex hormone-binding globulin: biomarker and hepatokine? Trends in Endocrinology and Metabolism. 2021;32(8):544-553. DOI: https://doi.org/10.1016/j.tem.2021.05.002</mixed-citation></ref><ref id="B17"><mixed-citation>Adewuyi EO, Sapkota Y, International Endogene Consortium, et al. Shared molecular genetic mechanisms underlie endometriosis and migraine comorbidity. Genes. 2020;11(3):268. DOI: https://doi.org/10.3390/genes11030268</mixed-citation></ref><ref id="B18"><mixed-citation>Sapkota Y, Steinthorsdottir V, Morris AP, et al. Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism. Nature Communications. 2017;8:15539. DOI: https://doi.org/10.1038/ncomms15539</mixed-citation></ref><ref id="B19"><mixed-citation>Garitazelaia A, Rueda-Mart&amp;iacute;nez A, Arauzo R, et al. A Systematic two-sample Mendelian randomization analysis identifies shared genetic origin of endometriosis and associated phenotypes. Life. 2021;11(1):24. DOI: https://doi.org/10.3390/life11010024</mixed-citation></ref><ref id="B20"><mixed-citation>Golovchenko I, Aizikovich B, Golovchenko O, et al. Sex Hormone Candidate Gene Polymorphisms Are Associated with Endometriosis. International Journal of Molecular Sciences. 2022;23(22):13691. DOI: https://doi.org/10.3390/ijms232213691</mixed-citation></ref><ref id="B21"><mixed-citation>Ponomarenko I, Pasenov K, Churnosova M, et al. Sex-Hormone-Binding Globulin Gene Polymorphisms and Breast Cancer Risk in Caucasian Women of Russia. International Journal of Molecular Sciences. 2024;25(4):2182. DOI: https://doi.org/10.3390/ijms25042182</mixed-citation></ref><ref id="B22"><mixed-citation>Lai Y, Zhang X, Zhang Z, et al. The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. International Journal of Oncology. 2013;42(2):776-784. DOI: https://doi.org/10.3892/ijo.2012.1743</mixed-citation></ref><ref id="B23"><mixed-citation>Deng N, Zhang X, Zhang Y. BAIAP2L1 accelerates breast cancer progression and chemoresistance by activating AKT signaling through binding with ribosomal protein L3. Cancer Science. 2023;114(3):764-780. DOI: https://doi.org/10.1111/cas.15632</mixed-citation></ref><ref id="B24"><mixed-citation>Renaud E, Riegel K, Romero R, et al. Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKC&amp;delta; for tumorigenesis. Molecular Cancer. 2022;21(1):195. DOI: https://doi.org/10.1186/s12943-022-01665-y</mixed-citation></ref><ref id="B25"><mixed-citation>Chao A, Tsai CL, Jung SM, et al. BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer. PLoS ONE. 2015;10(7):e0133081. DOI: https://doi.org/10.1371/journal.pone.0133081</mixed-citation></ref><ref id="B26"><mixed-citation>Coviello AD, Haring R, Wellons M, et al. A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation. PLoS Genetics. 2012;8(7):e1002805. DOI: https://doi.org/10.1371/journal.pgen.1002805</mixed-citation></ref><ref id="B27"><mixed-citation>Harrison S, Davies NM, Howe LD, et al. Testosterone and socioeconomic position: Mendelian randomization in 306,248 men and women in UK Biobank. Science Advances. 2021;7(31):eabf8257. DOI: https://doi.org/10.1126/sciadv.abf8257</mixed-citation></ref><ref id="B28"><mixed-citation>Qu X, Donnelly R. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome. International Journal of Molecular Sciences. 2020;21(21):8191. DOI: https://doi.org/10.3390/ijms21218191</mixed-citation></ref><ref id="B29"><mixed-citation>Dinsdale N, Nepomnaschy P, Crespi B. The evolutionary biology of endometriosis. Evolution, Medicine and Public Health. 2021;9(1):174-191. DOI: https://doi.org/10.1093/emph/eoab008</mixed-citation></ref><ref id="B30"><mixed-citation>Crespi B. Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model. Evolution, Medicine and Public Health. 2021;9(1):295-310. DOI: https://doi.org/10.1093/emph/eoab029</mixed-citation></ref><ref id="B31"><mixed-citation>Andreev AE, Kleimenova TS, Drobintseva AO, et al. Signal molecules involved in the formation of new nerve endings in endometriosis (review). Research Results in Biomedicine. 2019;5(1):94-107. Russian. DOI: https://doi.org/10.18413/2313-8955-2019-5-1-0-7</mixed-citation></ref><ref id="B32"><mixed-citation>Ponomarenko IV, Polonikov AV, Churnosov MI. Molecular mechanisms of and risk factors for endometriosis. Obstetrics and Gynecology. 2019;3:26-31. Russian. DOI: https://doi.org/10.18565/aig.2019.3.26-31</mixed-citation></ref><ref id="B33"><mixed-citation>Sinnott-Armstrong N, Naqvi S, Rivas M, et al. GWAS of three molecular traits highlights core genes and pathways alongside a highly polygenic background. eLife. 2021;10:e58615. DOI: https://doi.org/10.7554/eLife.58615</mixed-citation></ref><ref id="B34"><mixed-citation>Bulun SE. Endometriosis caused by retrograde menstruation: now demonstrated by DNA evidence. Fertility and Sterility. 2022;118(3):535-536. DOI: https://doi.org/10.1016/j.fertnstert.2022.07.012</mixed-citation></ref><ref id="B35"><mixed-citation>Pasenov KN. Features of associations of SHBG-related genes with breast cancer in women, depending on the presence of hereditary burden and mutations in the BRCA1/CHEK2 genes. Research Results in Biomedicine. 2024;10(1):69-88. Russian. DOI: https://doi.org/10.18413/2658-6533-2024-10-1-0-4</mixed-citation></ref><ref id="B36"><mixed-citation>Li Z, Wei H, Li S, et al. The Role of Progesterone Receptors in Breast Cancer. Drug Design, Development and Therapy. 2022;16:305-314. DOI: https://doi.org/10.2147/DDDT.S336643</mixed-citation></ref><ref id="B37"><mixed-citation>Yurchenkova KV, Smolyakova RM, Shpadaruk EM, and others. Assessment of the level of hormone excretion in peripheral blood in patients with breast cancer. In: Sakharov Readings 2020: Environmental problems of the 21st century. Proceedings of the 20th International Scientific Conference, May 21-22, 2020, Minsk. 2020;2:274-277. DOI: https://doi.org/10.46646/SAKH-2020-2-274-277</mixed-citation></ref><ref id="B38"><mixed-citation>Ruth KS, Campbell PJ, Chew S, et al. Genome-wide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. European Journal of Human Genetics. 2016;24(2):284-290. DOI: https://doi.org/10.1038/ejhg.2015.102</mixed-citation></ref><ref id="B39"><mixed-citation>Golovchenko I, Aizikovich B, Golovchenko O, et al. Sex Hormone Candidate Gene Polymorphisms Are Associated with Endometriosis. International Journal of Molecular Sciences. 2022;23(22):13691. DOI: https://doi.org/10.3390/ijms232213691</mixed-citation></ref><ref id="B40"><mixed-citation>Golovchenko IO. Genetic determinants of sex hormone levels in endometriosis patients. Research Results in Biomedicine. 2023;9(1):5-21. Russian. DOI: https://doi.org/10.18413/2658-6533-2023-9-1-0-1</mixed-citation></ref></ref-list></back></article>